Skip to main content

Published locations for HELIOS trial: Ibrutinib safely boosts survival in CLL/SLL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HELIOS trial: Ibrutinib safely boosts survival in CLL/SLL

User login

  • Reset your password
  • /content/helios-trial-ibrutinib-safely-boosts-survival-cll/sll
  • /hematologynews/article/102817/leukemia-myelodysplasia-transplantation/helios-trial-ibrutinib-safely
  • /oncologypractice/article/102817/leukemia-myelodysplasia-transplantation/helios-trial-ibrutinib
  • /hematology-oncology/article/102817/leukemia-myelodysplasia-transplantation/helios-trial-ibrutinib
  • /b-cell-lymphoma-icymi/article/102817/leukemia-myelodysplasia-transplantation/helios-trial-ibrutinib